下一个

自动播放

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

3 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放